Skip to content
Menu
Search
Search for:
Search
Technologies and services
Technologies and services
Small Molecules
Biologics
Pharmaceutical Development
Analytical Capabilities
GMP Manufacturing
STARMAP
®
Case Studies
Media Center
Media Center
Press releases
News
Articles and videos
Company events
Subscribe & contacts
Brochure
Sustainability Ebook
About Nanoform
About Nanoform
Vision, mission and values
Organization
Board of Directors
CEO and Management team
Success stories
Small is green
Investors
English
Investors
Svenska
Investerare
Finansiella rapporter och presentationer
Pressmeddelanden
Prenumeration och kontakter
Aktien och aktieägare
Aktieinformation
Ägarstruktur
Aktiekapitalets utveckling
Analytiker
Anmälan om betydande aktieägare
Transaktioner utförda av personer i ledande ställning
Kontakta oss
Investerarkalender
Certified Adviser
Börsnotering 2020
Suomeksi
Sijoittajat
Taloudelliset raportit ja esitykset
Tiedotteet
Tilaa lehdistötiedotteet
Osake ja osakkeeomistajat
Tiedot osakkeesta
Omistusrakenne
Osakepääoman kehitys
Analyytikot
Ilmoitukset merkittävistä osakkeenomistajist
Johtohenkilöiden liiketoimet
Yhteystiedot
Sijoittajakalenteri
Hyväksytty neuvonantaja
Listautuminen 2020
Financial Reports and Presentations
Press releases
Subscribe & contacts
Share and shareholders
Share information
Ownership structure
Share capital development
Analyst Coverage
Notification of major shareholdings
Manager Transactions
Contact Us
Investor calendar
Certified Adviser
IPO 2020
Corporate Governance
Corporate Governance
Corporate Governance Statements
General Meeting
Annual General Meeting 2023
General meetings
The Board of Directors
Board of Directors
Duties of the Board of Directors
Authorisations
Board committees
Remuneration of the Board
CEO and Management team
Remuneration
Audit
Internal Control and Risk Management
Code of conduct
Articles of Association
Insider administration
Disclosure policy
Transactions of managers
Careers
Contact Us
Investors
English
Investors
Svenska
Investerare
Finansiella rapporter och presentationer
Pressmeddelanden
Prenumeration och kontakter
Aktien och aktieägare
Aktieinformation
Ägarstruktur
Aktiekapitalets utveckling
Analytiker
Anmälan om betydande aktieägare
Transaktioner utförda av personer i ledande ställning
Kontakta oss
Investerarkalender
Certified Adviser
Börsnotering 2020
Suomeksi
Sijoittajat
Taloudelliset raportit ja esitykset
Tiedotteet
Tilaa lehdistötiedotteet
Osake ja osakkeeomistajat
Tiedot osakkeesta
Omistusrakenne
Osakepääoman kehitys
Analyytikot
Ilmoitukset merkittävistä osakkeenomistajist
Johtohenkilöiden liiketoimet
Yhteystiedot
Sijoittajakalenteri
Hyväksytty neuvonantaja
Listautuminen 2020
Financial Reports and Presentations
Press releases
Subscribe & contacts
Share and shareholders
Share information
Ownership structure
Share capital development
Analyst Coverage
Notification of major shareholdings
Manager Transactions
Contact Us
Investor calendar
Certified Adviser
IPO 2020
Corporate Governance
Corporate Governance
Corporate Governance Statements
General Meeting
Annual General Meeting 2023
General meetings
The Board of Directors
Board of Directors
Duties of the Board of Directors
Authorisations
Board committees
Remuneration of the Board
CEO and Management team
Remuneration
Audit
Internal Control and Risk Management
Code of conduct
Articles of Association
Insider administration
Disclosure policy
Transactions of managers
Careers
Contact Us
Investors
Financial Reports and Presentations
Years
All years
2023
2022
2021
2020
Presentation
All types
Annual report
Interim report
Presentation
Presentation
January 9, 2023
SEB Nordic Seminar in Copenhagen
October 25, 2022
Nanoform and TargTex – How drug delivery is enabling a clinical trial for Glioblastoma
June 4, 2021
Capital Markets Day 2021
Questions from investors, analysts and journalists
Discover more
